Kansas MPJE Final Exam 2023 With All Questions and Answers

Kansas MPJE Final Exam 2023 With All Questions and Answers ATF-1447 - ANSWER Form for hospital pharmacies needing to purchase large quantities of tax-free grain alcohol Form 41 - ANSWER Form to request permission to destroy damaged, outdated, or unwanted controlled substances Form 106 - ANSWER Form to report substantial theft or loss of controlled stubstances Form 222 - ANSWER Form used to order C-II controlled substances Form 222 - ANSWER Form used to send C-II controlled substances to a reverse distributor for disposal Form 222a - ANSWER Form used to order the forms used to order C-II controlled substances Form 224 - ANSWER Form used to apply for a new DEA dispenser registration Form 224a - ANSWER Form used to renew a DEA dispenser registration Form 224b - ANSWER Form used to renew a DEA dispenser registration for a retail chain Form 363 - ANSWER Form used to apply for a new DEA narcotic treatment program registration Form 363a - ANSWER Form used to renew a DEA narcotic treatment program registration Form 510 - ANSWER Form used to apply for a new DEA chemical distributor registration Form 2632 - ANSWER Application form for approval of use of narcotic drugs in a treatment program. Form 2633 - ANSWER DEA for for physicians authorized to administer and dispense narcotic drugs for treament of detoxification Form 2636 - ANSWER Form entitled Hospital Request for Methadone Detoxification Treatment C-III - ANSWER Controlled substance schedule of a preparation containing not more than 50 mg of morphine/100 mL or per 100g combined with non-narcotic active ingredients C-III - ANSWER Controlled substance schedule of buprenorphine SL C-V - ANSWER Controlled substance schedule of oral diphenoxylate with atropine C-V - ANSWER Controlled substance schedule of oral diphenoxylate/atropine 0 - ANSWER Number of times a C2 script can be transferred 0 - ANSWER Number of refills allowed for phentermine prescribed for obesity in Kansas 1 - ANSWER Number of consumer members on the Kansas Board of Pharmacy 1 - ANSWER Number of business days within which a pharmacy must notify the local DEA Diversion Field Office after discovery of theft or significant loss of a CS 1 - ANSWER Number of times a C3-C5 (with refills) can be transferred in Kansas if pharmacies do not share a real time computer system 2 - ANSWER Number of pharmacy students or interns a Kansas pharmacist preceptor may supervise 2 - ANSWER Number of years a vaccination protocol that establishes what vaccines a pharmacist may administer, procedures for record keeping, and emergency response is considered valid 3 - ANSWER Number of days a physician may administer a single day supply of methadone to a patient waiting for admission into narcotic treatment program 3 - ANSWER Number of years a DEA dispenser registration is valid 3.6 - ANSWER Number of grams maximum of pseudoephedrine base that may be sold to a single patient in a day 5 - ANSWER Number of times a pharmacist may refill a C3-C4 prescription if authorized 5 - ANSWER Number of days within which a PIC must notify the board of ceasing to serve as PIC 5 - ANSWER Number of years a pharmacist must practice in Kansas to serve on the Board of Pharmacy 5 - ANSWER Number of years which incident reports must be kept in Kansas 5 - ANSWER Number of years a pharmacy must keep controlled substance records after last entry (i.e., last refill) 6 - ANSWER Number of pharmacists on the Kansas Board of Pharmacy 6 - ANSWER Number of years HIPPA documentation, including signed acknowledgements of Notice of Privacy Practices, must be retained 6 - ANSWER Number of months a pharmacist may refill a C3-C4 if authorized 6 - ANSWER Number of months a C2 prescription is valid from issuance 7 - ANSWER Number of days pharmacist has to obtain the original prescription from a physician for an emergency C2 script 8 - ANSWER Number of months minimum between controlled substance inventories 9 - ANSWER Number of grams maximum of pseudoephedrine base that may be sold to a single patient in 30 days 12 - ANSWER Number of different OTC drugs maximum that may be offered for sale through a vending machine 12 - ANSWER Number of months maximum between controlled substance inventories 12 - ANSWER Number of months allowed to refill authorized C5 refills from the date of issuance 14 - ANSWER Number of days prior to a proposed transfer a registrant must notify the DEA prior to transferring to another registrant 18 - ANSWER Number of years minimum age of individuals allowed to purchase C5s OTC 24 - ANSWER Number of doses of codeine containing cough syrup that can be sold in 48 hours 30 - ANSWER Number of days within which a Kansas-licensed pharmacist must notify the Board of Pharmacy of any change of address 60 - ANSWER Number of days a drug wholesaler, acting as a supplier, has to complete a DEA Form 222 before it becomes void 60 - ANSWER Number of days to complete a partial fill on a C2 prescription for a patient diagnosed as terminally ill 60 - ANSWER Number of days allowed to complete a partial fill for a C2 prescription for a patient residing in a LTCF 72 - ANSWER Number of hours allowable to complete a partial fill for C2 for an ambulatory patient 72 - ANSWER Number of hours a pharmacist has to verify accuracy of the computer record for filling/refilling C3-C4 prescriptions 90 - ANSWER Number of days maximum supply that may be prescribed and dispensed on multiple C2 prescriptions with the same day of issuance 90 - ANSWER Number of mg maximum codeine per dosage unit combined with non-narcotic active ingredients to be scheduled as C3 120 - ANSWER Number of mL maximum of codeine-containing cough syrup that can be sold to a single patient in 48 hours 200 - ANSWER Number of mg maximum codeine per 100 ml or 100 g combined with non-narcotic active ingredients to be scheduled as a C5 QS - ANSWER Number of doses, maximum, of medication a hospital emergency room may provide to an outpatient when local retail pharmacies are closed and there is no pharmacist on the premises QS - ANSWER Number of doses, maximum, of C2 drug that may be prescribed and dispensed off of an emergency C2 script No Limit - ANSWER Number of doses, maximum, of C2 drug that may be prescribed and dispensed off of a single written C2 script Hydrocodone - ANSWER In Kansas, combination products containing this drug must be counted exactly during annual CS inventory, regardless of CS schedule Focused on Purity and Quality Prohibited the interstate transfer of adulterated or misbranded drugs Recognized USP/NF Standards - ANSWER Pure Food and Drug Act of 1906 Focused on Safety New drug cannot be marketed until proven safe (drugs prior to 1938 were exempt) Power given to Congress via authority over interstate commerce - ANSWER Food, Drug, and Cosmetic Act of 1938 Established 2 classes of drugs: Rx and OTC Established provisions for dispensing prescription drugs Established labeling requirements for OTC and prescription drugs Established use of NDC numbers - ANSWER Durham-Humphrey Amendment of 1951 Focused on safety AND efficacy Impacts all drugs after 1962 and new drugs with an NDA approved since 1938 Established effectiveness as a standard Established Good Manufacturing Practices (GMP) Transfered jurisdiction of Rx advertising from FTC to FDA - ANSWER Kefauver-Harris Amendments of 1962 All new and refilled scripts must be dispensed in child-proof container unless: Prescriber specifies for single prescription Patient indicates they do not want Container is being used in institution and maintained by health professionals SL Nitroglycerin or Isosorbide Potassium in UD form Aerosol containers for inhalation Oral Contraceptives or estrogens in dispenser pak Enforced by Consumer Product Safety Commission Failure to comply is MISBRANDING - ANSWER Poison Prevention Packaging Act of 1970 Classification of all devices into 3 classes based on the degree of control necessary to assue safety and effectiveness; most regulated are class 3 - ANSWER Medical Device Amendment of 1976 Federal offense to tamper with consumer products Requires tamper resistant packaging for OTC - ANSWER Federal Anti-Tampering Act of 1982 AKA Drug Price Competition and Patent Term Restoration Act Granted pharmaceutical manufacturers incentives by granting some market exclusivity Increased availability of generics Required FDA to publish an up-to-date list of all Rx and OTC drugs approved for safety and efficacy (The Orange Book) - ANSWER Waxman-Hatch Act of 1984 AKA Waxman-Hatch Act Granted pharmaceutical manufacturers incentives by granting some market exclusivity Increased availability of generics Required FDA to publish an up-to-date list of all Rx and OTC drugs approved for safety and efficacy (The Orange Book) - ANSWER Drug Price Competition and Patent Term Restoration Act of 1984 Prohibits sale, purchase, or trade or RX samples Restricts distribution to prescribers or hospital pharmacy (no retail pharmacy) Prescriber must write a written request for samples Guidelines for advertising Requires licensing of prescription drug wholesalers - ANSWER Prescription Drug Marketing Act of 1987 First fedeal law to directly address pharmacy practice standards Establised a federal policy requiring DUR (prospective instead of retrospective) Established standards of practice for pharmacists as a condition of participating in Medicaid program Rebates from "best price" go back to state Medicaid program - ANSWER Omnibus Reconciliation Act of 1990 (OBRA 90) Defined dietary supplements as foods rather than drugs and limited FDA's role in regulatioin Burden is on FDA to probe lack of safety prior to removal from market Defined specific claims manufacturers can make - ANSWER Dietary Supplement Health and Education Act of 1994 (DSHEA) Notice of privacy practices must be provided to patients When PHI used for a purpose not associated with treatment, payment, or operations (TPO) consent must be obtained Established training requirements and requirements for Privacy Officer - ANSWER Health Insurance Portability and Accountability Act of 1996 (HIPAA) Federal Compliance Guide regarding Pharmacy Compounding Changed the wording of required legend to "Rx Only" - ANSWER FDA Modernization Act of 1997 Added Part D (prescription drug benefit) to Medicare Provision for MTM Required development and implementation of standard for e-prescribing Permits importation of Rx drugs from Canada if HHS Secretary certifies safety - ANSWER Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Post marketing safety initiatives: Medguides, PPI, DTC advertising PPI must be dispensed each time Rx dispensed; in institutional setting given prior to first dose and every 30 days Provided FDA with the authority to impose risk evaluation and mitigation strategies (REMS) including Medguides and other restricted distribution programs - ANSWER Food and Drug Administration Amendments Act of 2007 (FDAAA) "Adequate directions for use" - ANSWER Labeling requirements for OTC Drugs "Adequate information for use" - ANSWER Labeling requirements for Rx Drugs established ANDA process (abbreviated new drug application for generics) Deals with the efficacy of drugs marketed between - ANSWER Drug Efficacy Study Implementation (DESI) one that supports or sustains human life or is of substantial importance in preventing impairment of human health or presents a potential, unreasonable risk of illness or injury - ANSWER Class 3 Medical Device Used if new drug is a newly discovered chemical or for an established drug offered in a new dosage form, with ne therapeutic claims, in new dosage levels, or for a different patient population - ANSWER New Drug Application (NDA) approval to market a generic - ANSWER Abbreviated New Drug Application (ANDA) investigational new drug - ANSWER IND application to allow a company to make changes to a product that already has an approved NDA. CDER must approve all changes to ensure that conditions originally set for the product are still met - ANSWER Supplemental New Drug Application (sNDA) Small number of patients (20-80) Evaluates safety Determines safe dosage range Identifies side effects - ANSWER FDA Clinical Trials Phase 1 Small number of patients with condition (100-300) Establishes testing protocol Establishes if drug is effective Further evaluates safety - ANSWER FDA Clinical Trials Phase 2 patients in a clinical setting Usually double-blinded Confirms effectiveness Monitors side effects Compares to commonly used treatments - ANSWER FDA Clinical Trials Phase 3 Post-marketing surveillance - ANSWER FDA Clinical Trials Phase 4 a preparation intended to supplement the diet and provide nutrients (such as vitamins, minerals, fiber, fatty acids, or amino acids) that may be missing or may not be consumed in sufficient quantities in a person's diet Must contain disclaimer that FDA has not evaluated and is not intended to "diagnose, treat, cure, or prevent any disease" - ANSWER Dietary supplement (also know as food or nutritional supplement) Required for Medicaid outpatient scripts as of 2008 Enacted as a fraud reducing measure Must contain features to prevent copying, erasure or modifcation, and the use of counterfeit forms - ANSWER Tamper Resistant Prescription Pads Regulated by FTC - ANSWER OTC Advertising Regulated by FDA - ANSWER Rx Advertising the quality or purity of the product is compromised; does not have the strength, quality or purity represented or expected; potentially contaminated or prepared under conditions not comforming to GMP - ANSWER Adulteration the act of labeling the product falsely or in a misleading way Refilling a prescription without authorization is misbranding - ANSWER Misbranding class of drugs sold only by a pharmacist or available only in a pharmacy - ANSWER Behind the Counter Drugs (BTC) Plans must have MTM program that may be provided by a pharmacist; pharmacists to be reimbursed for time spent counseling targeted patients - ANSWER Medication Therapy Management Services performed by DUR board of physicians and pharmacist to review medication use trends and data over a specified period of time and attempt to evaluate and improve medication use - ANSWER Retrospective Drug Use review actice resolution of drug therapy problems through a comprehensive review of a patient's prescription at the point of dispensing; includes screening prescriptions, counseling patients, and documentation - ANSWER Prospective Drug Use Review approved drug products with therapeutic equivalence evaluations - ANSWER Orange Book same active ingredient, identical strength, dosage form - ANSWER Orange Book: Pharmaceutical Equivalents bioequivalence, same clinical effect of safety profile when administered - ANSWER Orange Book: Therapeutic Equivalents therapeutically equivalent to the reference drug product - ANSWER Orange Book: Code A not considered therapeutically equivalent - ANSWER Orange Book: Code B drugs in conventional dosage forms, NO bioequivalence problem - ANSWER Orange Book: Code AA established scientific bioequivalence, any potential problems have been identified and resolved - ANSWER Orange Book: Code AB 1 - ANSWER Drug recall class presenting reasonable probability of serious adverse health consequences or death temporary or medically reversible adverse effects or remote possibility of serious adverse effects - ANSWER Drug recall class presenting risk of !!!!!! not likely to cause advers health effects - ANSWER Drug Recall: Class 3 used for FDA identification purposes, does not indicate approval status required on all drugs (RX and OTC) 1st 5 numbers: manufacturer/distributor 2nd 4 numbers: drug name and dosage form 3rd 2 numbers: package size - ANSWER National Drug Code (NDC) unlawful for any person not a state licensed pharmacist or any business that does not have a state licensed pharmacist in continuous employ to use or exhibit the words "pharmacy", "drugstore", or "apothecary" - ANSWER Kansas: Use of title "pharmacy" or "drugstore" Poisons Prescription meds Drugs containing ephedrine Drugs intended for human use by hypodermic injection - ANSWER Kansas: Vending machine items that cannot be sold Identification of the owner Toll free telephone number of the owner Statement advising purchaser to check expiration date prior to using Telephone number for the state board - ANSWER Kansas: Vending machine labeling requirements Poisons should be colored in such a way to make them readily distinguishable from food products - ANSWER Kansas: Conditions for the sale of a poison must be labeled by the manufacturer and seller Label muse contain description of all the contents of the solution, statement of purity, percent concentration of DMSO in solution, manufacturer name and address Seller must give additional printed material to the purchaser that provides adequate warning against use that may be dangerous to the health of the user - ANSWER Kansas: Labeling and Information requirements for selling non-prescription DMSO (dimethyl sulfoxide) A pharmacist or a pharmacy student or intern working under the direct supervision and control of a pharmacist may administer pursuant to a vaccination protocol if they have successfully completed an accredited course of study and training and have current CPR certificate (must be able to furnish proof of completion to the board upon request) - ANSWER Kansas: Vaccine Admisitration Guidelines Can administer to age 6 and older - ANSWER Kansas: Age restriction for flu vaccine Can administer to age 18 and older - ANSWER Kansas: Age restriction of vaccines (not flu) All vaccinees will be given a written immunization recod for their personal files Administration shall be promptly reported to the PCP by fax, mail, or other electronic means. If patient does not have a PCP, report to the physician who has entered the protocol Report to appropriate county or state immunization registries - ANSWER Kansas: Vaccine documentation Dispensing of a different drug product of the same dosage form, strength, and generic name than the brand name drug product prescribed Pharmacist may exercise brand exchange with a view toward achieving a lower cost for the patient unless marked DAW or FDA had determined not to be bioequivalent - ANSWER Kansas: Brand Exchange process by which the responsible pharmacist shall observe and direct the activities of a pharmacy student or technician to a sufficient degree to assure that all activities are performed accurately, safely, and without risk or harm to patients ***And to complete the final check before dispensing*** - ANSWER Kansas: Direct Supervision Person responsible to the board for a registered establishment's compliance with the laws and regulations of the state Must pass the law exam by 85% or higher - ANSWER Kansas: Pharmacist in charge an individual registered with the board and enrolled in an accredited school of pharmacy - ANSWER Kansas: Pharmacy student an individual, who under the direct supervision and control of a pharmacist may perform packaging, manipulative, repetitive, or other non-discretionary tasks related to the processing of a prescription; may not perform duties restricted to a pharmacist - ANSWER Kansas: Pharmacy Technician Licensed pharmacist with at least 2 years of experience as a pharmacist who supervises students obtaining pharmaceutical experience required by law - ANSWER Kansas: Preceptor A person selling at retail non-prescription drugs that are fully pre-packaged by the manufacturer or distributor and are labeled for consumer use in accordance with state and federal regulations - ANSWER Kansas: Retail Dealer a written protocol, agreed to by a pharmacist and a person licensed to practive medicine and surgery by the state board of healing arts, which establishes procedures and recordkeeping and reporting requirements for administering a vaccine by the pharmacist for a period of time specified within, not to exceed two years - ANSWER Kansas: Vaccine Protocol may not exceed two years - ANSWER Kansas: Vaccine Protocol time limit an individual who is a prospective candidate foe examination as a licensed pharmacist and who is qualified to receive and is obtaining pharmaceutical experience set forth in the pharmacy practice act Can be an intern without being a student - ANSWER Kansas: Pharmacy Intern Must register with the board and pay fee All submissions are the responsibility of the intern not the preceptor Requires 1500 hours (hours do not count before admission to pharmacy school or registration as an intern) - ANSWER Kansas: Pharmacy Intern requirements 1500 hours - ANSWER Kansas: Pharmacy Intern hour requirements 18 years old Graduate of an approved school Minimum of one year pharmaceutical experience under an approved preceptor Pass examination - ANSWER Kansas: Pharmacist qualifications for licensure License must be displayed in an area usually occupied or visible to the public License may not be displayed if not a business were pharmacist is actively involved in profession - ANSWER Kansas: Display of license May be licensed after taking law exam if already licensed in another state Shall file proof of training and educatuion to board Requirements based on requirements at the time of original licensure - ANSWER Kansas: Licensure by reciprocity shall provide proog of ability to communicate verbally and in written form in English must pass English as a foreign language exam (TOEFL) - ANSWER Kansas: Requirements of foreign grads June 30 biennial - ANSWER Kansas License renewal date $150 $200 if late - ANSWER Kansas: License Renewal Fee must notify the board in writing within 30 days - ANSWER Kansas: Change of Residential Address 3 CEU (30 hours) - ANSWER Kansas: Continuing Education Requirements May temporarily suspend or limit the license in accordance with emergency adjudicative proceedings; may revoke, suspend, or place in probationary status or deny renewal - ANSWER Kansas: Jurisdiction of the Board for License Revocation Revocation is for all time but can apply in one year for reinstatement - ANSWER Kansas: Hearings/appeals for License Revocation Pharmacist, student, intern, and pharmacy technician must wear name tags designated with function - ANSWER Kansas: Nametag Requirement Must register with the board Must pass exam approved by the board within 30 days of becoming registered Pharmacy must maintain list of techs employed by the pharmacy Registration must be displayed - ANSWER Kansas: Pharmacy Technician Registration $25 fee Expires 10-31 - ANSWER Kansas: Pharmacy Tech renewal Must notfy the board within 30 days of new employment - ANSWER Kansas: Pharmacy Tech Job Change Must complete training course within 180 days of employment Pharmacy keeps records of name and address of tech, date training course started, name and address of pharmacy - ANSWER Kansas: Pharmacy Tech Training Course 1 RPh: 2 techs (if not certified) 1 RPh: 3 techs (if certified) - ANSWER Kansas: Pharmacy Tech Ratio Term is 4 years Serve a maximum of 2 terms - ANSWER Kansas: Board of Pharmacy Term Appointed by the Governor - ANSWER Kansas: Board of Pharmacy Appointment May inspect in a lawful manner drugs kept or for sale in Kansas pharmacy - ANSWER Kansas: Board of Pharmacy Inspection Authority USP/NF and Homeopathic Pharmacopeia - ANSWER References Officially Recognized by FDCA A pharmacist or non-pharmacist as designated in a current and properly executed power of attorney A pharmacist or non-pharmacist who signed the most recent DEA application for a controlled substance registration - ANSWER Whom has the authority to sign a DEA-222 C2 in one file, C3-5 in one file, non-controlleds in 3rd file C2 scripts in one file, C3-5 and non-controlleds together - ANSWER Approved DEA filing methods for prescriptions Must notify the board in writing within 5 days of decision to quit as PIC - ANSWER Kansas: Change in PIC notification to board Medical dictionary Recognized reference in drug interactions Copy of the Kansas Controlled Substance Act and regulations - ANSWER Kansas: Required references for community pharmacy (3) Name and address of patient Initial date of dispensing and prescription number Name of the dispensing pharmacist Drug allergies and sensitivities - ANSWER Kansas: Requirements for community pharmacy medication profile record may be written, telephonic, or electronic Blank written orders must have two signature lines Prescription ordes shall be recorded in writing by the pharmacist and the record so made constitutes an original prescription A prescription is an order received for OUTpatients A medication order is for INpatients - ANSWER Kansas: Prescription Format Cannot fill a prescription copy A copy issued for reference must bear "This prescription copy is issued for reference only" - ANSWER Kansas: Prescription Copies rescription for the drug was issued with a valid pre-existing patient-prescriber relationship rather than an internet or telephone consultation - ANSWER Kansas: Pharmacist Function in filling Rx: Legitimate Medical Purpose Judgmental functions that constitute filling or refillin can only be performed by a pharmacist or pharmacy student under the direct supervision of a pharmacist. Only non-judgmental duties associated with preparation can be designated to a tech; in process and final checks must be done by a pharmacist - ANSWER Kansas: Pharmacist Function in filling Rx: Judgmental Functions Must be issued within the course of professional practice for legitimate medical purpose Must identify the transmitter's phone for verbal confirmation; date and time of transmission; identity of pharmacy to receive Must be transmitted by prescriber or designated agent May be saved as a hard copy or as an electronic document - ANSWER Kansas: Electronic Prescription Transmission May be transmitted electronically - ANSWER Kansas: Electronic Prescription Transmission C3-5 Escript counts as hard copy for C2 order to be compounded for direct administration to patient by injection C2 order for resident of nursing facility, nursing facility for mental health, or assisted living facility C2 order for patient released by registered institution to a home hospice setting that continues to provide care - ANSWER Kansas: Electronic Prescription Transmission C2 (3 cases where acceptable) Quantity prescribed and dispensed limited to amount adequate to treat patient during emergency Must be reduced immediately to hard copy Prescriber must issue a written prescription within 7 days and write on the face "authorization for emergency dispensing" and date of the transmitted Rx order Upon receipt of written order, attach to hard copy, notify DEA if no written Rx received - ANSWER Kansas: Emergency Script for C2 prescriber must issue within 7 days - ANSWER Kansas: Emergency Script for C2: time to receive written order Limited to one year from date of origin Controlled Substances limited to 6 months or 5 refills Refill at will: no limitation to the number of times it may be refilled except may not be refilled after the expiration of the time specified or one year (whichever is first) - ANSWER Kansas: Refill limitations May refill without authorization (not controlled substance) when all reasonable efforts to contact the prescriber have failed and in the pharmacist's professional judgment continuation is necessary for patient health and welfare. May only refill amount sufficient to maintain patient until provider can be contacted; no more than 7 days or one package. May not fill if prescriber states on Rx "no emergency filling" - ANSWER Kansas: Refill without authorization 7 days or one package May not fill if prescriber states on Rx "no emergency filling" - ANSWER Kansas: Refill without authorization limits The Kansas Board of Pharmacy shall submit to the Speaker of the House of Representatives and the President of the Senate a report on substances proposed by the Board for scheduling, rescheduling , or deletion by the legislature. - ANSWER Kansas: Drug Scheduling Cannot distribute C2-C5 samples (differs from Federal Law) - ANSWER Kansas: Controlled Substance Samples Must be maintained on file for no less than 5 years from the date of last entry in the record. - ANSWER Kansas: Controlled Substance Records A prescription may not be issued in order for a practitioner to obtain CS for supplying himself or any other practitioner for the purpose of general dispensing to patients - ANSWER Kansas: Controlled Substance for provider use CS C2-C5 may not be issued on a prescription blank which is preprinted with the name of a proprietary preparation or strength or quantity or directions - ANSWER Kansas: Controlled Substance Preprinted Blanks Controlled substance prescriptions C3-C5 may be transmitted by telephone by a prescriber or designated agent to the pharmacy. The transmission may be oral or by fax. If telephoned or faxed by other than the prescriber, the prescription shall bear the name of the person so transmitting the prescription. - ANSWER Kansas: Telephone/Fax C3-C5 scripts All written or emergency scripts for a C2 medication must be cancelled on the face of the prescription with the name of the pharmacist filling it - ANSWER Kansas: Cancelling C2 scripts by pharmacist All written or emergency scripts for a C2 medication must be cancelled with the name of the pharmacy intern and the preceptor authorizing filling the prescription - ANSWER Kansas: Cancelling C2 Scripts by intern A C2 script is valid for 6 months from its date of issuance (no limit in federal law) - ANSWER Kansas: C2 Script Length of Validity C2 and narcotic drugs listed in any schedule are exceptions to the 7-day emergency refilling allowance - ANSWER Kansas: Emergency refill of narcs Resigning PIC must inventory prior to leaving position, new PIC must inventory all CS within 72 hours or beginning to function as PIC - ANSWER Kansas: CS Inventory with PIC change C2 substances and products containing Hydrocodone must be counted exactly - ANSWER Kansas: CS Inventory Exact Count Defined as "drug paraphenalia" - ANSWER Kansas: Hypodermic needle designation Amphetamines will not be dispensed or prescribed to treat obesity - ANSWER KS: Treatment of Obesity with Amphetamines Physician shall personally take complete history and document it Physician shall prescribe nutritional counseling, including behavior modification and exercise for weight loss, and record those on the patient record The physician shall not dispense more that a 30 day supply of CS at one time The physician must monitor the patient and record the findings in the patient chart with each visit The physician shall not dispense or prescribe additional CS to treat obesity for a patient who was not achieved a weight loss of at least 5% during initial 90 days Law does not cover methylphenidate or pemoline - ANSWER Kansas: Treatment of Obesity Physician may not prescribe nor dispense more than a 30 day supply - ANSWER Kansas: Obesity Treatment Supply A physician shall not dispense or prescribe additional CS to treat obesity for a patient who has not achieved a weight loss of at least 5% during the initial 90 days - ANSWER Kansas: Long-term Obesity Treatment used by FDA for identification purposes, does not indicate approval status - ANSWER NDC combination of two official compendi: the United States Pharmacopeia (USP) and the National Formulary USP: Mongraphs for drug substances, dosage forms, compounded preparations; dietary supplements appear in separate section NF: Excipient monographs Drug product in US must conform to USP/NF standards to avoid possible charges of adulteration or misbranding - ANSWER USP/NF Every place occupied or used for the preparation for sale, manufacture, packing, storage, sale or distribution of any food or drug shall be properly lightd, drained, plumbed, ventilated and screened Conducted with strict regart to the influence of such condition upon the puruty and wholesomeness of foods or drugs therein produced Enforced by the Secretary of Health and Environment - ANSWER Kansas: Condition of places the sell drugs unlawful for any person not a state licensed phamracist or any business that does not have a state licensed pharmacist in continuous employ to use or exhibit the words "pharmacy", "drugstore", or "apothecary" - ANSWER Kansas: Use of the title "pharmacy" or "drugstore" must be colored in such a way to make them readily distinguishable from food products - ANSWER Kansas: Conditions for sale of poison Label shall contain a description of all contents of the solution, staement of purity, the percent of DMSO in the solution, the manufactures name and address Seller or supplier muse provide addtional prointent material to the person receiving that provides adequate warning against use that may be dangerous to the health of the user - ANSWER Kansas: Labeling requirements for selling non-prescription DMSO (dimethyl sulfoxide) Direct application of a drug, whether by injection, inhalation, ingection or other means by a practioner pursant to the lawful direction of a practioner. Nothing contained in the pharmacy act shall prohibit a duly licensed practioner from purchasing and keeping drugs, from compounding precriptions, or from adminsitering, supplying or dispensing to such practioner's patients such drugs as may be fit, proper, and necessary - ANSWER Kansas: administer A pharmacist or pharmacy student or intern working under the direct supervision and control of a pharmacist may administer influenza vaccine to a person 6 or older and may administer other vaccines to a person 18 or older pursuant to a vaccine protocol if the individual has successfully completed an accredited course of study and training and has current CPR certification - ANSWER Kansas: Vaccine Administration Requirements Pharmacist, pharmacy student, or intern Age 6 and up - ANSWER Kansas: Flu shot requirements Pharmacist, pharmacy student, or intern Age 18 and up - ANSWER Kansas: Vaccine requirements (not flu) All vaccinees will be given a written immunization record for their personal files Administration shall be promptly reported to PCP by mail, fax, or other electronic means. If patient does not have PCP it shall be eported to physician whom has entered the protocol. Immunization will also be reported to appropriate county or state immunization registries. - ANSWER Kansas: Vaccine Record